| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/05/2006 | WO2006002195A2 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 01/05/2006 | WO2006002127A1 Transdermal delivery system for statin combination therapy |
| 01/05/2006 | WO2006002112A1 Devices, articles, coatings, and methods for controlled active agent release |
| 01/05/2006 | WO2006002077A2 Stable pharmaceutical formulations of benzimidazole compounds |
| 01/05/2006 | WO2006002067A1 Composition and method using local application of lipophilic lathyrogens in sustained release formulations |
| 01/05/2006 | WO2006002050A1 Phospholipid compositions and methods for their preparation and use |
| 01/05/2006 | WO2006002032A1 Sustained release neutralized divalproex sodium |
| 01/05/2006 | WO2006002031A1 Sustained release dosage forms |
| 01/05/2006 | WO2006001963A1 Pharmaceutical compositions comprising cyclosporins |
| 01/05/2006 | WO2006001962A1 Bicarbonate-based peritoneal dialysis solutions |
| 01/05/2006 | WO2006001815A1 Active agents using liposome macro-beads |
| 01/05/2006 | WO2006001046A1 Hydrogels of hyaluronic acid and alpha, beta-polyaspartylhydrazide and their biomedical and pharmaceutical uses |
| 01/05/2006 | WO2006001035A2 Synergistic liposomal tamoxifen composition for topical application and method of preparing thereof. |
| 01/05/2006 | WO2006001022A1 Novel electrodes and uses thereof |
| 01/05/2006 | WO2006000652A1 Method for the preparation of essential oils in a form facilitating the risk-free ingestion thereof |
| 01/05/2006 | WO2006000592A1 Use of ether group-containing polymers as solubilizers |
| 01/05/2006 | WO2006000583A2 Oral sustained release formulation of tedisamil with gastric retention properties |
| 01/05/2006 | WO2006000455A1 Bioactive composition, seawater-based preparation method, use thereof for genital hygiene and device for using same |
| 01/05/2006 | WO2006000347A1 Aqueous dispersions of low-water-solubility or water-insoluble active substances and dry powders produced therefrom |
| 01/05/2006 | WO2006000304A1 Wound dressing |
| 01/05/2006 | WO2006000272A2 Device for the targeted release of substances in a cavity |
| 01/05/2006 | WO2006000233A1 Tobacco alkaloid containing chewing gum |
| 01/05/2006 | WO2006000232A1 Tobacco alkaloid releasing chewing gum |
| 01/05/2006 | WO2006000229A2 Porous tablets as carriers for liquid formulations |
| 01/05/2006 | WO2006000228A2 Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 01/05/2006 | WO2006000137A1 Oral disintegrable tablet of notogingseng total sapoin and the preparation process thereof |
| 01/05/2006 | WO2005116131B1 A dried and agglomerated hyaluronic acid product |
| 01/05/2006 | WO2005102248A3 Silicone vesicles containing actives |
| 01/05/2006 | WO2005097079A3 Controlled release dosage for gaba receptor agonist |
| 01/05/2006 | WO2005097076A3 Low dose pharmaceutical products |
| 01/05/2006 | WO2005089772A3 Prevention of loss of tight cell junctions using carbohydrate-containing compositions |
| 01/05/2006 | WO2005089448A3 Administration of cisplatin by inhalation |
| 01/05/2006 | WO2005079763A3 Compression-coated tablets and manufacture thereof |
| 01/05/2006 | WO2005072745A3 Aqueous solutions comprising prednisolone and a cyclodextrin derivative |
| 01/05/2006 | WO2005070003A3 Abuse potential reduction in abusable substance dosage form |
| 01/05/2006 | WO2005060540A3 Norethindrone sustained release transdermal formulation |
| 01/05/2006 | WO2005057163A3 Method to fabricate microcapsules from polymers and charged nanoparticles |
| 01/05/2006 | WO2005051347A3 A simple process and formulation for making taste- masked ibuprofen liquid preparations and similar good-tasting preparation of other pharmaceutically active or bitter, poor tasting compounds for the production of liquid preparations |
| 01/05/2006 | WO2005049073A3 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 01/05/2006 | WO2005037192A3 Ibuprofen narcotic composition and method for making same |
| 01/05/2006 | WO2005027874A3 Solid or semi-solid therapeutic formulations |
| 01/05/2006 | WO2005011570A3 Calcium carbonate granulation |
| 01/05/2006 | WO2004071453A3 Compositions and methods for treatment of pouchitis |
| 01/05/2006 | US20060004456 Intervertebral disc treatment devices and methods |
| 01/05/2006 | US20060004417 Baroreflex activation for arrhythmia treatment |
| 01/05/2006 | US20060004286 Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses |
| 01/05/2006 | US20060004193 Viscoelastic material |
| 01/05/2006 | US20060004089 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 01/05/2006 | US20060004054 Administering 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline before or at the time angioplasty, coronary by-pass grafting or stent implantation |
| 01/05/2006 | US20060003989 Compositions and methods using acetylcholinesterase (ACE) inhibitors to treat central nervous system (CNS) disorders in mammals |
| 01/05/2006 | US20060003984 Monobactam compositions and methods of use thereof |
| 01/05/2006 | US20060003977 Tibolone-adsorbates |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003949 Freeze-dried preparation of stabilized anthracycline compound |
| 01/05/2006 | US20060003947 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
| 01/05/2006 | US20060003025 comprising from 1300 to 1500 mg/l of Na+, from 4500 to 6500 mg/l of K+, from 50 to 1300 mg/l of Mg++, from 20 to 350 mg/l of ca++, from 4000 to 6000 mg/l of Cl-, a pH of from 4-9, and an osmolality of from 150-700 mOsm/kg; for treating and cleaning the eye |
| 01/05/2006 | US20060003014 Safe delivery system for agriculturally active material |
| 01/05/2006 | US20060003013 Spheres comprising multi-carbide material with a mass density greater than 8 gm/cc and a hardness and toughness sufficient not to introduce contamination of resulting milled oxides to a degree greater than 200 ppm; high fracture toughness |
| 01/05/2006 | US20060003012 Preparation of submicron solid particle suspensions by sonication of multiphase systems |
| 01/05/2006 | US20060003011 Pharmaceutical compositions of drugs and neutralized acidic polymers |
| 01/05/2006 | US20060003010 Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same |
| 01/05/2006 | US20060003009 Slow release protein polymers |
| 01/05/2006 | US20060003008 Polymeric devices for controlled release of active agents |
| 01/05/2006 | US20060003007 Controlled extended drug release technology |
| 01/05/2006 | US20060003006 Controlled delivery system for bioactive substances |
| 01/05/2006 | US20060003005 Tablet for pulsed delivery |
| 01/05/2006 | US20060003004 Pulsatile release compositions of milnacipran |
| 01/05/2006 | US20060003003 Oral sustained release formulation of tedisamil with gastric retention properties |
| 01/05/2006 | US20060003002 Pharmaceutical compositions with synchronized solubilizer release |
| 01/05/2006 | US20060003001 Chronotherapeutic compositions and methods of their use |
| 01/05/2006 | US20060003000 Adhesively bonded dosage form |
| 01/05/2006 | US20060002999 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane |
| 01/05/2006 | US20060002998 Pharmaceutical dosage forms of biguanide-sulfonylurea combinations |
| 01/05/2006 | US20060002997 Nitrofurantoin controlled release dosage form |
| 01/05/2006 | US20060002996 Stable spray-dried protein formulations |
| 01/05/2006 | US20060002995 Pharmaceutical porous particles |
| 01/05/2006 | US20060002994 Responsive liposomes for ultrasonic drug delivery |
| 01/05/2006 | US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response |
| 01/05/2006 | US20060002992 Atomizable liposomes and their use for the pulmonary administration of active substances |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | US20060002989 Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
| 01/05/2006 | US20060002987 Dissolvable film composition |
| 01/05/2006 | US20060002986 Pharmaceutical product |
| 01/05/2006 | US20060002982 Xanthan gum viscoelastic composition, method of use and package |
| 01/05/2006 | US20060002971 encapsulate therapeutic compounds such as drugs, cellular materials or components, and antigens, and can have targeting ligands directly bound to the microparticle surface; tissue engineering matrices, wound dressings, bone repair or regeneration materials |
| 01/05/2006 | US20060002966 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 01/05/2006 | US20060002960 GM1 binding deficient exotoxins for use as immunoadjuvants |
| 01/05/2006 | US20060002908 Bifidobacterium in the treatment of inflammatory disease |
| 01/05/2006 | US20060002881 Perfluorocarbon-soluble compounds |
| 01/05/2006 | US20060002874 Topical pharmaceutical composition to treat hyperpigmentation of the skin |
| 01/05/2006 | US20060002870 Cosmetic compositions and methods containing a tanning agent and liposome encapsulated ursolic acid |
| 01/05/2006 | US20060002864 Milling process for the production of finely milled medicinal substances |
| 01/05/2006 | US20060002863 Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant |
| 01/05/2006 | US20060002862 High pressure spray-dry of bioactive materials |
| 01/05/2006 | US20060002861 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist |
| 01/05/2006 | US20060002852 Targeted and high density drug loaded polymeric materials |
| 01/05/2006 | DE102004028986A1 Pellet, useful to prepare pharmaceutical preparations and administer antibiotic, antiasthmatic- and broncholytic-drug, comprises a core containing a water-soluble carrier e.g. mannitol and an active agent |
| 01/05/2006 | DE102004028977A1 Pellet, useful to prepare pharmaceutical preparations and administer therapeutically and/or prophylactically active substances e.g. antirheumatic-, antidiabetic- or antiallergic- drug, comprises a water-soluble carrier e.g. mannitol |
| 01/05/2006 | DE102004028975A1 Pharmaceutical pellet, useful for preparing tablets, comprises a spherical shaped active substance core with smooth surface and a coat (which induces the release of the active substance, independent of the pH) on the core |
| 01/05/2006 | DE102004028284A1 Matrixkontrolliertes transdermales therapeutisches System auf Basis eines Schmelzklebstoffs zur Anwendung von Norelgestromin Controlled matrix transdermal therapeutic system based on a hot melt adhesive for use of norelgestromin |